According to the latest report by IMARC Group, titled “Theranostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global theranostics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/theranostics-market/requestsample
Theranostics refers to a combination of several radioactive drugs and techniques that are utilized to diagnose, deliver therapy, treat life-threatening illnesses, etc. It is cost-effective and involves pharmacogenetics, proteomics, biomarker profiling, etc. Theranostics is integrated with nanomedicine to target specific organs and tissues and enhance patient-specific outcomes. Researchers worldwide are currently developing new diagnostic and therapeutic agents for theranostics to personalize cancer treatment, improve the quality care of pharmacotherapy, reduce side effects of treatment, etc.
The growing prevalence of cancer due to the rising consumption of tobacco and alcohol, low nutrition intake, and lack of physical activity represents one of the primary factors driving the theranostics market. Besides this, the elevating awareness towards the availability of advanced medical treatments and improving healthcare infrastructures are propelling the market growth. Moreover, the escalating demand for personalized medicines is further augmenting the product demand. Apart from this, the growing integration of seamless, multiple imaging treatment technologies within a single nanoparticle to tackle pathologies is also catalyzing the global market. Additionally, the increasing investments in research and development (R&D) activities are anticipated to propel the growth of the market in the coming years.
Theranostics Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global theranostics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- Agilent Technologies Inc.
- AmeriPath Inc (Quest Diagnostics Incorporated)
- Beckman Coulter Inc. (Danaher Corporation)
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- General Electric Company
- Illumina Inc.
- Myriad Genetics Inc.
- Pfizer Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the global theranostics market on the basis of disease type, technology, end user and region.
Breakup by Disease Type:
- Neurological Disorders
- Cardiovascular Diseases
- Immunological Disorders
- Oncology Diseases
- Others
Breakup by Technology:
- Polymerase Chain Reaction
- Immunohistochemistry
- In-Situ Hybridization
- Sequencing
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/theranostics-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
